These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10072186)

  • 1. The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.
    Rosier JF; Beauduin M; Bruniaux M; de Bast M; de Coster B; Octave-Prignot M; Scalliet P; Grégoire V
    Int J Radiat Biol; 1999 Feb; 75(2):245-51. PubMed ID: 10072186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.
    Rosier JF; Bruniaux M; Husson B; Octave-Prignot M; Beauduin M; Grégoire V
    Radiother Oncol; 2004 Jan; 70(1):55-61. PubMed ID: 15036853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
    Rosier JF; Michaux L; Ameye G; Cedervall B; Libouton JM; Octave-Prignot M; Verellen-Dumoulin C; Scalliet P; Grégoire V
    Mutat Res; 2003 Jun; 527(1-2):15-26. PubMed ID: 12787910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine].
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Ramm U; Damrau M; Rahn A; Böttcher HD
    Strahlenther Onkol; 1999 Feb; 175(2):78-83. PubMed ID: 10065143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines.
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Damrau M; Ramm U; Rahn A; Böttcher HD
    Anticancer Res; 2000; 20(1A):401-5. PubMed ID: 10769687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptin enhances radiation-induced cell death in poorly responding head and neck squamous cell carcinoma cells.
    Schoop RA; Verdegaal EM; Baatenburg de Jong RJ; Noteborn MH
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):130-4. PubMed ID: 19874285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].
    Miao JW; Kong WM; Zhang WH; Niu JW; Deng XH
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):342-5. PubMed ID: 15196420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation enhancement by gemcitabine-mediated cell cycle modulations.
    Mose S; Class R; Weber HW; Rahn A; Brady LW; Böttcher HD
    Am J Clin Oncol; 2003 Feb; 26(1):60-9. PubMed ID: 12576927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
    Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J
    Oncologist; 2016 Jan; 21(1):59-71. PubMed ID: 26712958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis.
    Grégoire V; Beauduin M; Bruniaux M; De Coster B; Octave Prignot M; Scalliet P
    Int J Radiat Biol; 1998 May; 73(5):511-20. PubMed ID: 9652808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas.
    Chauhan A; Singh H; Sharma T; Manocha KK
    Afr Health Sci; 2008 Sep; 8(3):149-55. PubMed ID: 19357741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.
    van Bree C; Castro Kreder N; Loves WJ; Franken NA; Peters GJ; Haveman J
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):237-44. PubMed ID: 12182997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.
    Grégoire V; Rosier JF; De Bast M; Bruniaux M; De Coster B; Octave-Prignot M; Scalliet P
    Radiother Oncol; 2002 Jun; 63(3):329-38. PubMed ID: 12142097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells.
    van Bree C; Rodermond H; Leen R; Medema J; van Kuilenburg A
    Br J Cancer; 2008 Apr; 98(7):1226-33. PubMed ID: 18349845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7).
    Pradier O; Rave-Fränk M; Schmidberger H; Bömecke M; Lehmann J; Meden H; Hess CF
    J Cancer Res Clin Oncol; 1999; 125(1):20-7. PubMed ID: 10037273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective targeting of homologous DNA recombination repair by gemcitabine.
    Wachters FM; van Putten JW; Maring JG; Zdzienicka MZ; Groen HJ; Kampinga HH
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):553-62. PubMed ID: 12957269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.
    Grégoire V; Beauduin M; Rosier JF; De Coster B; Bruniaux M; Octave-Prignot M; Scalliet P
    Br J Cancer; 1997; 76(10):1315-21. PubMed ID: 9374377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction between cisplatin and gemcitabine in vitro.
    Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Peters GJ
    Clin Cancer Res; 1996 Mar; 2(3):521-30. PubMed ID: 9816199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell lines.
    Rohde D; Hayn HK; Blatter J; Jakse G
    Int J Oncol; 1998 Jun; 12(6):1361-6. PubMed ID: 9592200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.